Augusts 29, 2024

New algorithm facilitates personalized treatments for genetic disorders and cancer

The RTD detective computational model, developed by CRG researchers and published in Nature Genetics, predicts the efficacy of drugs for pathologies caused by genetic mutations. Based on data from more than 5000 patients, the system promises to accelerate the development of targeted therapies and optimize clinical trials.
Augusts 28, 2024

Conference “Promotion of cardiovascular health in the work environment” in Zaragoza

Ibercaja Foundation, in collaboration with the Aragón Health Research Institute (IIS Aragón), presents on October 3 the conference “Promotion of cardiovascular health in the work environment”, with the aim of raising awareness and promoting the importance of promoting health at work, valuing its benefits.
Augusts 27, 2024

Marta Lalinde: “Childhood cancer research is a great challenge that needs time and resources”

Marta Lalinde is the clinical trials coordinator of the Pediatric Oncohematology Unit of the Miguel Servet Children's Hospital in Zaragoza. She has been in this newly created position for two and a half years, which is funded equally by Aspanoa and IIS Aragón.
Augusts 26, 2024

RNA 'sequestration' silences the development of acute myeloid leukemia

An international study, published in the journal Nature Cell Biology, offers a new perspective to better understand the malignant transformation of cells that occurs in this disease.
Augusts 22, 2024

A research project seeks to reduce childhood obesity with the help of one hundred families in Aragon

The IIS Aragón has been collaborating since 2019 in the 'Meli-POP' study to prevent childhood obesity. We work with children who were then between 3 and 6 years old and who will be followed up until adolescence.